(Q37750518)

22 August 2017

1 reference

title

Microarchitecture in focus (English)

1 reference

22 August 2017

R Rizzoli

1

1 reference

22 August 2017

language of work or name

English

0 references

publication date

13 May 2010

1 reference

Osteoporosis International

22 August 2017

published in

1 reference

22 August 2017

volume

21 Suppl 2

1 reference

22 August 2017

page(s)

S403-6

1 reference

Bone mineral density thresholds for pharmacological intervention to prevent fractures

22 August 2017

cites work

1 reference

12 December 2020

Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents

1 reference

12 December 2020

Assessment of cancellous bone structure: comparison of strut analysis, trabecular bone pattern factor, and marrow space star volume.

1 reference

12 December 2020

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

12 December 2020

A review of strontium ranelate and its effect on DXA scans

1 reference

12 December 2020

Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group

1 reference

12 December 2020

Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment

1 reference

12 December 2020

Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density

1 reference

12 December 2020

The correction of BMD measurements for bone strontium content.

1 reference

12 December 2020

Histomorphometric and microCT analysis of bone biopsies from postmenopausal osteoporotic women treated with strontium ranelate.

1 reference

12 December 2020

Technology insight: noninvasive assessment of bone strength in osteoporosis

1 reference

12 December 2020

Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy

1 reference

12 December 2020

Advanced CT bone imaging in osteoporosis

1 reference

12 December 2020

In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.

1 reference

12 December 2020

Revival of bone strength: the bottom line

1 reference

12 December 2020

Management of osteoporosis in the elderly.

1 reference

12 December 2020

Relationship between bone mineral density changes and fracture risk reduction in patients treated with strontium ranelate

1 reference

12 December 2020

Microarchitecture, the key to bone quality

1 reference

12 December 2020

Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs

1 reference

12 December 2020

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

1 reference

12 December 2020

Bone density and shape as determinants of bone strength in IGF-I and/or pamidronate-treated ovariectomized rats

1 reference

12 December 2020

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

12 December 2020

Bone biology and the pathogenesis of osteoporosis

1 reference

12 December 2020

Relationship between change in femoral neck bone mineral density and hip fracture incidence during treatment with strontium ranelate

1 reference

12 December 2020

Advanced imaging of bone macrostructure and microstructure in bone fragility and fracture repair

1 reference

12 December 2020

Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study

1 reference

12 December 2020

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates

1 reference

12 December 2020

10.1007/S00198-010-1242-1

Identifiers

DOI

1 reference

22 August 2017

1 reference